Log in to save to my catalogue

Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant...

Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_3109_10837450_2014_898657

Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma

About this item

Full title

Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma

Publisher

England: Informa Healthcare

Journal title

Pharmaceutical development and technology, 2015-01, Vol.20 (5), p.562-569

Language

English

Formats

Publication information

Publisher

England: Informa Healthcare

More information

Scope and Contents

Contents

Infant hemangioma (IH) is the most common tumor in infants, which affects 5-10% of white children. It is a tumor of vascular origin that appears in the first months of life. The indication for the treatment of the IH is not approved in the datasheet of the product, however it has been used in the infant hemangioma by topical administration as an al...

Alternative Titles

Full title

Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_3109_10837450_2014_898657

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_3109_10837450_2014_898657

Other Identifiers

ISSN

1083-7450

E-ISSN

1097-9867

DOI

10.3109/10837450.2014.898657

How to access this item